Kim Warren
Biochemistry
AVROBIO
Canada
Biography
Kim is an experienced scientist with entrepreneurial and business management experience in cell therapy. She spent the last 10 years at Lonza, developing a services business, including tissue acquisition, process development, bioassays and related services to support GMP manufacturing of cellular therapeutics. Kim also headed R&D at Cambrex, developing cell-based research products. She founded and ran Poietic Technologies, acquired by Cambrex in 1999. She has also held research positions in pharma (Otsuka) and biotech (Cetus). Kim has a Ph.D. in Comparative Physiology from University of Maryland and postdoctoral training in Immunology at USUHS, Bethesda MD. Kim is an experienced scientist with entrepreneurial and business management experience in cell therapy. She spent the last 10 years at Lonza, developing a services business, including tissue acquisition, process development, bioassays and related services to support GMP manufacturing of cellular therapeutics. Kim also headed R&D at Cambrex, developing cell-based research products. She founded and ran Poietic Technologies, acquired by Cambrex in 1999. She has also held research positions in pharma (Otsuka) and biotech (Cetus). Kim has a Ph.D. in Comparative Physiology from University of Maryland and postdoctoral training in Immunology at USUHS, Bethesda MD.
Research Interest
Biochemistry